Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand

Journal of Clinical Pharmacy and Therapeutics

Volumn 30, Issue 1, 2005, Pages 13-20

  Janchawee, Benjamas ^a   Wongpoowarak, W ^a   Owatranporn, T ^a   Chongsuvivatwong, V ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Drug interactions; Hospital; Outpatients; Prescriptions; Rate

Indexed keywords

DIGITALIS GLYCOSIDE; DIGOXIN; ISONIAZID; LOOP DIURETIC AGENT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RIFAMPICIN; SULFONAMIDE; THIAZIDE DIURETIC AGENT; FUROSEMIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; OUTPATIENT; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; RISK FACTOR; THAILAND; UNIVERSITY HOSPITAL; AGE; CLASSIFICATION; COMPARATIVE STUDY; DRUG COMBINATION; DRUG CONTRAINDICATION; DRUG INTERACTION; DRUG UTILIZATION; HOSPITAL PHARMACY; METHODOLOGY; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; STATISTICS; TIME; UTILIZATION REVIEW;

ADULT; AGE FACTORS; DIGOXIN; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; FUROSEMIDE; HOSPITALS, UNIVERSITY; HUMANS; ISONIAZID; MALE; MIDDLE AGED; OUTPATIENTS; PHARMACOEPIDEMIOLOGY; PHARMACY SERVICE, HOSPITAL; PRESCRIPTIONS, DRUG; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RIFAMPIN; THAILAND; TIME FACTORS;

EID: 23844537873     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2004.00598.x     Document Type: Article

References (44)

1. Boston Collaborative Drug Surveillance Program (1972) Adverse drug interactions. The Journal of the American Medical Association, 220, 1238-1239.
2. May FE, Stewart RB, Cluff LE (1977) Drug interactions and multiple drug administration. Clinical Pharmacology and Therapeutics, 22, 322-328.
3. Prince BS, Goetz CM, Rihn TL, Olsky M (1992) Drug-related emergency department visits and hospital admissions. American Journal of Hospital Pharmacy, 49, 1696-1700.
4. Hamilton RA, Briceland LL, Andritz MH (1998) Frequency of hospitalization after exposure to known drug-drug interactions in Medicaid population. Pharmacotherapy, 18, 1112-1120.
5. Shad MU, Marsh C, Preskorn SH (2001) The economic consequences of a drug-drug interaction. Journal of Clinical Psychopharmacology, 21, 119-120.
6. McDonnell PJ, Jacobs MR (2002) Hospital admissions resulting from preventable adverse drug reactions. The Annals of Pharmacotherapy, 36, 1331-1336.
7. Anonymous (1972) Risk of drug interaction may exist in 1 of 13 prescriptions. The Journal of the American Medical Association, 220, 1287-1288.
8. Mitchell GW, Stanaszek WF, Nichols NB (1979) Documenting drug-drug interactions in ambulatory patients. American Journal of Hospital Pharmacy, 36, 653-657.
9. Gosney M, Tallis R (1984) Prescription of contraindicated and interacting drugs in elderly patients admitted to hospital. Lancet, 2, 564-567.
10. Kurfees JF, Dotson RL (1987) Drug interactions in elderly. The Journal of Family Practice, 25, 477-488.
11. Costa AJ (1991) Potential drug interactions in an ambulatory geriatric population. Family Practice, 8, 234-236.
12. McKenzie LC, Kimberlin CL, Pendergast JF, Berardo DH (1994) Potential drug interactions in a high risk ambulatory elderly population. Journal of Geriatric Drug Therapy, 28, 49-63.
13. Muranaka M, Nagai N, Watanabe M, Hata H, Takenaka K (1994) Investigation of prescriptions given to outpatients in seven Kosei-nenkin hospitals. Japanese Journal of Hospital Pharmacy, 20, 442-453.
14. Bergendal L, Friberg A, Schaffrath A (1995) Potential drug-drug interactions in 5125 mostly elderly outpatients in Gothenburg, Sweden. Pharmacy World and Science, 17, 152-157.
15. Dwiprahasto I, Kristin E (1995) Drug interaction due to inappropriate prescribing for children under 10 years: an evaluation of prescribing pattern among private practices in Indonesia. Pharmacoepidemiology and Drug Safety, 4, S28.
16. Chan TYK, Lam BSY, Ng NKL, Critchley JAJH (1996) Drug interactions in general medical patients. Pharmacoepidemiology and Drug Safety, 5, S108.
17. Grönroos PE, Irjala KM, Huupponen RK, Scheinin H, Forsström J, Forsström JJ (1997) A medication database: a tool for detecting drug interactions in hospital. Pharmacoepidemiology and Drug Safety, 53, 13-17.
18. Heininger-Rothbucher D, Bischinger S, Ulmer H, Pechlaner C, Speer G, Wiedermann CJ (2001) Incidence and risk of potential adverse drug interactions in the emergency room. Resuscitation, 49, 283-288.
19. Bjorkman IK, Fastbom J, Schmidt IK, Bernsten CB (2002) Drug-drug interactions in elderly. The Annals of Pharmacotherapy, 36, 1675-1681.
20. Ho YF, Huang SH, Lin HN (2002) Detecting drug-drug interactions in medication profiles of psychiatric inpatients: a two stage approach. Journal of The Formosan Medical Association, 101, 294-297.
21. Kittiwongsuntorn A (1994) Antacid adverse drug interaction of out-patient prescription at Surin Hospital. Medical Journal of Srisaket Surin Buriram Hospitals, 9, 268-278.
22. Lertwicha S, Chaimongkol S, Wanapongpisan W (1996) The study of possible drug interaction of fluoroquinolone in outpatient: Sawanpracharak Hospital. Region 8 Medical Journal, 4, 157-168.
23. Pajongrak U (1996) Antacid interaction in out-patient at Banpong Hospital. Region 7 Medical Journal, 15, 479-488.
24. Wisuthi S, Chansirikarnjana S (1997) Cardiovascular drug interactions in elderly patients. Mahidol University Annual Research Abstracts, 24, 112.
25. Supakan M, Jittasarttra P, Sridakul S, Suwanmalee W, Janjaratjit S (1995) A study of potentially important drug, drug interaction on outpatients in regional and general hospitals in the V zones. Medical Journal of Srisaket Surin Buriram Hospitals, 10, 145-171.
26. Pol-udom W, Komkai S (1996) Potentially important drug interaction in outpatients of Maharat Nakhon Ratchasima Hospital. Maharat Nakhon Ratchasima Hospital Medical Bulletin, 20, 165-172.
27. Weerutamasaen P (1994) Incidence rate of couple drugs that might cause drug interactions in outpatients of Chaoprayayommaraj Hospital, Suphanburi by number of drug items. Bulletin of the Department of Medical Services, 19, 460-464.
28. Janchawee B, Wongpoowarak P, Amnuaypanit C, Wamae M, Ovartlarnporn T, Chongsuvivatwong V (2003) Development and trial of the drug interaction database system. Songklanakarin Journal of Science and Technology, 25, 525-534.
29. Hansten PD, Horn JR (1998) Hansten and Horn's Managing Clinically Important Drug Interactions. Vancouver, BC, Canada: Applied Therapeutics.
30. Zucchero FJ, Hogan MJ, Schultz CD, Curran JP, Bremerkamp JP (1999) Evaluations of Drug Interactions. St Louis, MO, USA: First DataBank.
31. Tatro DS (2000) Drug Interaction Facts 2000. St Louis, MO, USA: Facts and Comparisons.
32. Wongpoowarak W, Wongpoowarak P (2002) Unified algorithm for real-time detection of drug interaction and drug allergy. Computer Methods and Programs in Biomedicine, 68, 63-72.
33. Nolan L, O'Malley K (1989) The need for a more rational approach to drug prescribing for elderly people in nursing homes. Age and Ageing, 18, 52-56.
34. Stewart RB, Cooper JW (1994) Polypharmacy in the aged practical solutions. Drugs and Aging, 4, 449-461.
35. Pessayre D, Bentata M, Degott C, Nouel O, Miguet JP, Rueff B, Benhamou JP (1977) Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction. Gastroenterology, 72, 284-289.
36. O'Brien RJ, Long MW, Cross FS, Lyle MA, Snider DE, Jr (1983) Hepatotoxicity from isoniazid and rifampin among children treated for tuberculosis. Pediatrics, 72, 491-499.
37. Leary WP, Reyes AJ (1984) Diuretic-induced magnesium losses. Drugs, 28(Suppl. 1), 182-187.
38. Hollifield JW (1986) Thiazide treatment of hypertension. Effects of thaizide diuretics on serum potassium, magnesium, and ventricular ectopy. American Journal of Medicine, 80, 8-12.
39. Maiche AG (1986) Acute renal failure due to concomitant action of methotrexate and indomethacin. Lancet, 1, 1390.
40. Singh RR, Malaviya AN, Pandey JN, Guleria JS (1986) Fatal interaction between methotrexate and naproxen. Lancet, 1, 1390.
41. Stockley IH (1987) Methotrexate-NSAID interactions. Drug Intelligence and Clinical Pharmacy, 21, 546.
42. Thomas MH, Gutterman LA (1986) Methotrexate toxicity in a patient receiving trimethoprim-sulfamethoxazole. Journal of Rheumatology, 13, 440-441.
43. Frain JB (1987) Methotrexate toxicity in a patient receiving trimethoprim-sulfamethoxazole. Journal of Rheumatology, 14, 176-177.
44. Govert JA, Patton S, Fine RL (1992) Pancytopenia from using trimethoprim and methotrexate. Annals of Internal Medicine, 117, 877-878.